Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.

The role of c-myc in prostatic carcinogenesis is poorly understood. The pathogenetic relationship between high-grade prostatic intraepithelial neoplasia (PIN), prostatic carcinoma, and metastases is not well-defined. We used fluorescence in situ hybridization (FISH) with a region-specific probe for c-myc (band 8q24) and chromosome enumeration probes for chromosomes 7, 8, 10, 12, and Y to evaluate genetic changes in matched PIN (48 foci), localized prostatic carcinoma (71 foci), and lymph node metastases (23 foci) in 25 totally embedded whole-mount stage D1 (T2-3 N1-3 M0) radical prostatectomy and pelvic lymphadenectomy specimens. The c-myc protein expression in these lesions was evaluated by immunohistochemistry. Foci with extra copies of c-myc could be divided into three groups: (a) those with simple gain of a whole chromosome 8 (no increase in c-myc copy number relative to the chromosome 8 centromere), which was identified in 42, 25, and 46% of foci of PIN, carcinoma, and metastases, respectively; (b) those with an intermediate increase in c-myc copy number relative to the chromosome 8 centromere, which was found in 8, 11, and 25% of foci of PIN, carcinoma, and metastases, respectively; and (c) those with substantial amplification of c-myc (large increases in c-myc copy number relative to the chromosome 8 centromere), which was detected in 0, 8, and 21% of foci of PIN, carcinoma, and metastases, respectively. Substantial amplification of c-myc was strongly correlated with increasing cancer nuclear grade and immunohistochemical evidence of c-myc protein overexpression. Numeric chromosomal anomalies were found in 67, 68, and 96% of foci of PIN, carcinoma, and metastases, respectively. The most frequent anomaly in PIN and carcinoma was a gain of chromosome 8, and the presence of this anomaly strongly correlated with Gleason score. Carcinoma foci usually contained more FISH anomalies than paired PIN foci, but three prostates contained one or more PIN foci with more anomalies than carcinoma. Thirteen primary tumor foci exhibited intratumor genetic heterogeneity by FISH. One or more foci of the primary tumor usually shared FISH anomalies with the matched metastases. Our FISH results indicate that: (a) gain of chromosome 8 and amplification of c-myc are potential markers of prostate carcinoma progression; (b) PIN is likely a precursor of carcinoma; (c) intraglandular and intratumoral genetic heterogeneity is relatively common; and (d) usually a single focus of cancer gives rise to metastases.

[1]  D. Bostwick,et al.  The extent and multicentricity of high-grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma. , 1997, Human pathology.

[2]  D. Bostwick,et al.  Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. , 1995, Cancer research.

[3]  N. Konishi,et al.  Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma. , 1995, The American journal of pathology.

[4]  D. Bostwick,et al.  Atypical Adenomatous Hyperplasia of the Prostate: Relationship with Carcinoma in 217 Whole‐mount Radical Prostatectomies , 1995, The American journal of surgical pathology.

[5]  David G. Bostwick,et al.  High grade prostatic intraepithelial neoplasia. The most likely precursor of prostate cancer , 1995 .

[6]  T. H. van der Kwast,et al.  Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: Analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias , 1995, Genes, chromosomes & cancer.

[7]  Jorma Isola,et al.  In vivo amplification of the androgen receptor gene and progression of human prostate cancer , 1995, Nature Genetics.

[8]  T. Visakorpi,et al.  Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. , 1995, Cancer research.

[9]  P. Roy-Burman,et al.  Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer. , 1995, The American journal of pathology.

[10]  M. Bittner,et al.  DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  B. Wullich,et al.  DNA aneuploidy in prostatic adenocarcinoma: a frequent event as shown by fluorescence in situ DNA hybridization. , 1994, Human pathology.

[12]  R. Bookstein,et al.  Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer , 1994, Genes, chromosomes & cancer.

[13]  R. Jenkins,et al.  Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma. , 1994, The Journal of urology.

[14]  D. Bostwick,et al.  Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies. , 1994, The American journal of surgical pathology.

[15]  E. Bergstralh,et al.  Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. , 1994, Cancer research.

[16]  W. Sakr,et al.  Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. , 1994, Cancer research.

[17]  D. Bostwick,et al.  Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. , 1994, Cancer research.

[18]  D. Grignon,et al.  Allelic loss in locally metastatic, multisampled prostate cancer. , 1994, Cancer research.

[19]  P. Scardino,et al.  Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological features. , 1994, The Journal of urology.

[20]  W. Sakr,et al.  Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis , 1993, Genes, chromosomes & cancer.

[21]  D. Lane,et al.  ras-Induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation , 1992, Cell.

[22]  W. Sakr,et al.  Loss of the 17p chromosomal region in a metastatic carcinoma of the prostate. , 1992, The Journal of urology.

[23]  E. Liu,et al.  Alterations of the P53 gene are associated with the progression of a human prostate carcinoma. , 1992, The Journal of urology.

[24]  F. Alt,et al.  myc family oncogenes in the development of normal and neoplastic cells. , 1991, Advances in cancer research.

[25]  H. Adami,et al.  NATURAL HISTORY OF LOCALISED PROSTATIC CANCER A Population-based Study in 223 Untreated Patients , 1989, The Lancet.

[26]  T. Stamey,et al.  Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis. , 1988, American journal of clinical pathology.

[27]  D. Bostwick,et al.  Prostatic Intra‐Epithelial Neoplasia and Early Invasion in Prostate Cancer , 1987, Cancer.

[28]  D. Bostwick,et al.  Intraductal dysplasia: a premalignant lesion of the prostate. , 1986, Human pathology.